| | |
| | | |
|
| Carl Zeiss Meditec Offers Entire Spectrum of Cataract Surgery Solution | Downloads and Links | ||||
| | | Broad portfolio of diagnostic, treatment and follow-up products at ASCRS annual meeting DUBLIN/California/USA, 04/06/2009. An entire suite of cataract surgery solutions, including diagnostics for pre- and post-treatment as well as implantable intraocular lenses (IOLs) and disposables, will be showcased at the American Society of Cataract and Refractive Surgery (ASCRS) meeting in San Francisco by Carl Zeiss Meditec, a leader in complete ophthalmic systems including IOLs and disposables. “We are excited to offer comprehensive cataract solutions to help surgeons provide the highest quality of care to the growing number of cataract patients worldwide,” said Michael Kaschke, PhD, President and Chief Executive Officer of Carl Zeiss Meditec. “While our long history and experience in ophthalmology has allowed us to pioneer a vast number of technologies for this market, we also work to ensure that each individual product demonstrates significant value to the practice by implementing practice management benefits and by positively impacting patient outcomes.” Complete Cataract Portfolio
New Offerings for the Refractive Surgeon The Visante® omni is the first system to combine OCT and Placido disk technologies, providing comprehensive anterior and posterior topography for improved patient selection and care. Linking two of ZEISS’ most trusted platforms (the Atlas™ corneal topographer with Visante® OCT), the new Visante® omni allows the refractive surgeon to identify pre-existing corneal abnormalities, such as keratoconus, in their earliest stages. “Combining OCT pachymetry with Placido disk technology may provide the most precise information possible about the back surface of the cornea,” said Jack Holladay, MD, of Holladay Lasik Institute in Houston, TX. “In addition, the Visante® omni Holladay report allows physicians to access patient-specific data sets in a simple, one page printout to maximize workflow and practice efficiencies.” The new 500 kHz VisuMax® Femtosecond System is more than twice the speed of the 200 kHz system, treatment times are reduced from approximately 20-25 seconds to just ten seconds per eye. Laser spot density has also been increased by approximately twenty percent, facilitating more consistent flap lifts and smoother stromal beds. This new 500 kHz upgrade works seamlessly with the existing VisuMax® platform with no programming modifications required by the surgeon. “The major advantage of the 500 kilohertz upgrade is that it allows for shorter treatment times with increased laser spot density,” said Jon Dishler, MD, of Dishler Laser Institute in Greenwood Village, CO. “Clinically, this produces two significant benefits. First, the higher repetition rate reduces the actual laser emission time, which is the critical phase of the procedure. Thus, the patient is required to remain still for a very short amount of time. Secondly, the higher spot density results in even more precise tissue separation.” Refractive outcomes for the VisuMax® Femtosecond System and the MEL 80™ excimer laser will be presented at the "Refractive Surgical Outcomes" symposium on Monday, April 6 from 7 pm to 9.15 pm at the Parc 55 Hotel. New clinical results will be presented by the Lisa Toric user group during the concurrent “Cataract and Refractive Surgery Outcomes” symposium. New Independent Market Research A new market research report compiled by Market Scope Reports will be available to customers and meeting attendees. These research findings demonstrate that while refractive surgery procedures remain relatively flat in today’s current environment, a 35 percent increase is expected to take place between 2008 and 2012. Cataract procedures are also anticipated to increase by nearly 13 percent between 2008 and 2012 and 25 percent between 2008 and 2015. These trends are due to an overall decline in the number of practicing ophthalmologists in the coming years combined with an increase in the aging population that will require more medical intervention, particularly in eye care. Please visit booth #1926 to receive a complimentary copy of this report. Jackie Ferreira Phone: 925-557-4488 Fax: - E-Mail: j.ferreira@meditec.zeiss.com Number: 009/09 Number of Words: 892 Number of Signs: 6234 | | RTF Documents
english (60 KB) |
Go To Top
To Overview |